rapamycin
mTOR
autophagy
longevity
Aging
science
health
metformin
Cellular Senescence
rapamycin
mTOR
autophagy
longevity
Aging
science
health
metformin
Cellular Senescence
10 min read

Rapamycin Cost: What You'll Actually Pay for a Longevity Prescription

written by

Healthspan Team

published08 / 10 / 2026
Take Home Points

Compounded rapamycin typically costs $20-60/month — a fraction of brand-name Rapamune's price for the same molecule.

Insurance almost never covers off-label longevity use. Budget out-of-pocket and use generic or compounded options to keep costs down.

The cheapest rapamycin isn't always the best deal — sourcing from unverified overseas suppliers means no quality control and no one watching your labs.

Baseline labs and ongoing monitoring aren't optional extras. They're what separates a protocol from a guess.

You are not a mouse. The longevity data is promising, but human trials are still maturing — go in with realistic expectations.

Clinical supervision is what turns rapamycin from a risky experiment into a managed, evidence-informed protocol.

The Drug Everyone in Longevity Is Talking About — And the Price Tag No One Breaks Down

If you've spent any time in longevity circles lately, you've heard about rapamycin. It's the prescription drug that extends lifespan in every animal model researchers have thrown at it. It's the molecule that Bryan Johnson, Peter Attia, and a growing number of longevity-focused physicians are either taking or actively discussing. And it's something your regular GP probably hasn't brought up once.

But here's where most articles stop: they explain what rapamycin does, maybe cite a mouse study or two, and then leave you staring at your browser with the obvious follow-up question completely unanswered. What does rapamycin actually cost? Can insurance cover it? Is there a cheaper version? Is a $20 pill and a $400 pill the same thing?

This article answers all of that, with real numbers. No hype, no hand-waving. By the end, you'll know exactly what a rapamycin longevity protocol costs, what drives the price variation, and how to get access to it without overpaying or going it alone.

What Is Rapamycin, Really?

Quick context before the numbers, because it matters for understanding why pricing is so complicated. Rapamycin (generic name: sirolimus) was discovered in 1972 in a soil sample from Easter Island — Rapa Nui, which is literally where the name comes from. It was originally developed as an antifungal, then repurposed as an immunosuppressant for organ transplant patients. It's been FDA-approved for that use since 1999 under the brand name Rapamune.

The longevity angle came later. Rapamycin inhibits a protein called mTOR (mechanistic target of rapamycin), which acts like a throttle for cellular growth and aging. When mTOR is dialed down, cells shift from a "grow fast, divide now" mode into a more careful, maintenance-oriented state. They clean up cellular debris through a process called autophagy (your cells' built-in recycling system), become more stress-resistant, and appear to age more slowly. In mice, rapamycin extended lifespan by 10-25%, even when started in middle age.

The longevity use case is "off-label" — meaning the FDA hasn't approved it for aging. That one fact drives almost everything about how rapamycin is priced and whether insurance will touch it.

Rapamycin Cost: The Real Numbers

Here's the breakdown you actually came here for. Rapamycin pricing falls into three categories: brand-name, generic, and compounded. They are not the same price. Not even close.

Brand-Name Rapamune: The Most Expensive Option

Rapamune is the original branded formulation made by Pfizer. Without insurance, a 30-tablet supply of 1mg Rapamune runs roughly $800 to $1,500 per month at a standard US retail pharmacy. At the doses used in longevity protocols (typically 2-6mg once weekly), your monthly cost for branded Rapamune can range from $200 to $900+ depending on dose and pharmacy, but that's still a significant outlay. Some specialty pharmacies charge more.

Here's the catch: even the "lower" branded cost assumes you're using a discount card or have found a favorable pharmacy price. Cash-pay at a random retail pharmacy? You could easily see prices at the higher end of that range or above it.

Generic Sirolimus: Significantly Cheaper, Same Molecule

Generic sirolimus (the same active compound as Rapamune) became more widely available after Pfizer's patents expired. At retail pharmacies with a GoodRx or similar discount card, generic sirolimus tablets typically run $50 to $200 per month for longevity doses. The exact price depends on dose, tablet count, and pharmacy. Some people report getting 4mg/week for under $30/month with the right discount program at the right pharmacy. Others pay closer to $150.

This is a workable price point for many people, and the generic is bioequivalent to Rapamune. For most longevity protocols, there's no clinical reason to pay for the brand name.

Compounded Rapamycin: The Most Affordable Option

Compounded rapamycin is where the cost floor really drops. Compounding pharmacies can prepare rapamycin capsules (or sometimes oral solutions) at a fraction of the retail cost. Compounded rapamycin typically costs $20 to $60 per month for standard longevity doses, making it the most cost-accessible route for most people.

There's a nuance here worth naming. Compounded drugs aren't FDA-approved as finished products — they're prepared by a licensed compounding pharmacy on a per-prescription basis. The quality of compounded rapamycin can vary by pharmacy. Working with a clinic that has vetted, high-quality compounding partners matters more than most people realize. More on that in a moment.

Quick Cost Comparison Summary

  • Brand-name Rapamune (no insurance): $200-$1,500+/month depending on dose
  • Generic sirolimus (with discount card): $30-$200/month
  • Compounded rapamycin: $20-$60/month
  • Physician consultation and monitoring: Variable; often $100-$300 for initial visit, ongoing check-ins additional

Will Insurance Cover Rapamycin for Longevity?

Almost certainly not, and here's why: insurance covers FDA-approved indications. Rapamycin is approved for organ transplant rejection and a few rare lung diseases. Longevity and healthy aging are not on that list.

If your doctor writes a prescription for an "approved" indication and you happen to also be interested in longevity, theoretically coverage could apply. But most longevity-focused physicians prescribing rapamycin off-label will tell you upfront: don't count on insurance. Some insurers will flat-out deny the claim. Others may cover it then claw it back later. It's not worth structuring your protocol around a coverage that probably won't stick.

The practical answer: budget for out-of-pocket costs and use the compounded or generic route to keep those costs reasonable. For most people using compounded rapamycin through a supervised clinic, the monthly drug cost is genuinely comparable to a gym membership or a few quality supplements.

GoodRx and Discount Cards for Generic Sirolimus

If you go the generic sirolimus route at a retail pharmacy, GoodRx is your friend. Prices vary dramatically by pharmacy — the same prescription can be $40 at one chain and $180 at another. Always check GoodRx, RxSaver, and the pharmacy's own discount program before filling. At Costco Pharmacy, for example, generic sirolimus is often among the cheapest options available. It takes five minutes to compare and can save you $100+ per month.

What Actually Drives the Price Difference?

It's worth understanding why these price points exist so far apart, because it affects how you think about the tradeoffs.

Brand vs. generic: Standard pharmaceutical economics. Once a patent expires, generic manufacturers can enter the market and drive the price down. The molecule is identical; you're paying for marketing and branding with Rapamune.

Retail pharmacy vs. compounding pharmacy: Retail pharmacies stock finished, FDA-approved tablets. Compounding pharmacies make the medication to order. The compound bypasses the retail supply chain markup, which is why it's cheaper. The tradeoff is that quality control is the pharmacy's responsibility rather than the FDA's, which is why the source matters.

Dose: Longevity protocols typically use rapamycin once weekly at doses between 2mg and 10mg. Transplant patients use it daily at much higher doses. Because longevity dosing is relatively low and infrequent, your monthly tablet count is modest — which keeps costs down compared to the transplant context.

The Hidden Cost Nobody Talks About: Going Without Medical Supervision

Here's where the cost conversation gets more complicated. Some people source rapamycin from overseas pharmacies or grey-market suppliers to avoid the prescription process entirely. The prices look attractive: sometimes $10-20 per month for unverified pills.

This is a bad idea, and not because of some abstract liability concern. Rapamycin is an immunosuppressant. At longevity doses it's relatively mild, but it's not zero-risk. Without labs, you can't tell if it's affecting your lipids (it often raises triglycerides), your immune function, or your wound healing. Without a physician who knows your history, you won't catch interactions with other medications. And with unverified sources, you genuinely don't know what's in the capsule.

The actual cost of going unsupervised isn't in the drug price — it's in the risk of missing something a $200 lipid panel would have caught in ten minutes.

The Reality Check on Rapamycin's Longevity Promise

Before we talk about how to access this affordably and safely, a necessary pause. The evidence for rapamycin in humans is promising but not settled. The mouse data is genuinely impressive. The mechanistic rationale is solid. But the controlled human longevity trials are still in early stages. You are not a mouse.

Observational data from physicians who've been prescribing off-label rapamycin for years is encouraging — many report improvements in metabolic markers, immune function markers, and subjective energy. But "my patients feel better" isn't a randomized controlled trial. The PEARL trial and other ongoing studies should give us much better human data within the next few years.

What we can say: rapamycin has a 50-year safety record in a more intensive immunosuppressant context (transplant medicine). Longevity dosing — lower, intermittent — appears to have a substantially milder side effect profile. Most people on longevity protocols tolerate it well. But "most people" isn't "everyone," and that's exactly why clinical oversight is part of the deal.

Who Is Rapamycin Actually Right For?

Rapamycin for longevity isn't for everyone, and being honest about that is more useful than a broad pitch. You're probably a good candidate if:

  • You're in your 40s, 50s, or 60s and thinking seriously about healthspan, not just feeling generally healthy
  • You've already done the basics well: decent metabolic health, not significantly overweight, not on medications that interact with mTOR inhibition
  • You're willing to get labs done before starting and periodically while you're on it
  • You understand this is an off-label use with real but manageable uncertainty
  • You're not currently immunocompromised, pregnant, planning surgery, or dealing with active infections

If you're 35 and otherwise healthy, the risk-benefit calculation is less clear — the potential upside is real but so is the unknown horizon of a 30+ year protocol. If you're 70 with multiple comorbidities, it deserves a more careful look with a physician who knows your full picture. Neither of those situations is "no." They're just "not without a real conversation first."

Risks and Side Effects Worth Knowing

Rapamycin's side effect profile at longevity doses is generally mild, but not nothing. The most commonly reported issues:

  • Mouth sores (oral ulcers): The most frequent complaint at higher doses; often manageable by adjusting dose or frequency
  • Elevated triglycerides: mTOR inhibition affects lipid metabolism; monitoring lipids is standard practice
  • Mild immune suppression: At longevity doses this is subtle, but worth tracking if you get frequent infections
  • Delayed wound healing: A known mechanism; relevant if you're having elective surgery (standard protocol is to pause rapamycin beforehand)
  • Drug interactions: Rapamycin is metabolized by the same liver enzyme as many common drugs; a medication review before starting matters

Most of these are dose-dependent, manageable, and detectable with basic labs. That's not a reason to avoid rapamycin — it's a reason to not do it without someone checking your numbers.

How to Get Started: The Healthspan Approach to Rapamycin

If you've read this far and you're thinking "this sounds worth exploring," here's what that looks like in practice through Healthspan.

The Rapamycin Protocol at Healthspan is a clinically supervised program, not a script-and-goodbye transaction. Here's what it actually includes:

  • Baseline labs: Lipid panel, metabolic panel, CBC, and other relevant markers before you start — so there's a real picture of where you're starting from
  • Physician consultation: A clinician reviews your history, current medications, and health goals. If rapamycin isn't right for you, they'll tell you that, not just take your money
  • Compounded rapamycin through a vetted pharmacy: This is how the cost stays in the $20-60/month range — Healthspan uses high-quality compounding partners, not random offshore suppliers
  • Ongoing monitoring: Labs at appropriate intervals to track lipids, immune markers, and anything else relevant to your protocol
  • Dose optimization: Protocols aren't one-size-fits-all; the starting dose and eventual maintenance dose get adjusted based on your response and labs

The total cost of a supervised protocol through Healthspan is meaningfully more than buying mystery pills from an overseas website. It's also meaningfully less than what most people spend on supplements that have nowhere near the evidence base. And it's the difference between a protocol and a gamble.

If you're also interested in complementary longevity interventions, Healthspan offers Longevity Optimization, which combines multiple evidence-based protocols into a coordinated approach. Some people pair rapamycin with Metformin, another off-label longevity drug with its own solid evidence base and very low cost, worth exploring if you want to understand what a stacked protocol looks like.

Ready to find out whether rapamycin makes sense for you? Start with The Rapamycin Protocol — the first step is a consultation, not a commitment.

Frequently Asked Questions About Rapamycin Cost

How much does rapamycin cost per month for longevity?

It depends on the source. Compounded rapamycin through a supervised clinic typically costs $20-60 per month. Generic sirolimus at a retail pharmacy with a discount card runs $30-200 per month depending on dose and pharmacy. Brand-name Rapamune without insurance can cost $200-1,500+ per month. Most people using rapamycin for longevity use compounded or generic versions to keep costs manageable.

Does insurance cover rapamycin for longevity or anti-aging?

No, insurance almost never covers rapamycin prescribed off-label for longevity. Rapamycin is FDA-approved for organ transplant rejection, not aging. Because longevity use is off-label, insurers will deny coverage in the vast majority of cases. The practical approach is to budget for out-of-pocket costs and use the compounded or generic route, which brings the monthly cost down significantly.

Is compounded rapamycin safe?

Compounded rapamycin from a reputable, licensed compounding pharmacy is considered safe and effective by most longevity physicians. The key word is "reputable" — quality control varies by pharmacy. Working with a supervised clinic that has vetted compounding partners significantly reduces this risk. The active molecule is the same as FDA-approved sirolimus; the difference is the manufacturing process.

What is the difference between Rapamune and generic sirolimus?

Rapamune is the brand-name version of sirolimus made by Pfizer. Generic sirolimus contains the identical active molecule and is considered bioequivalent by the FDA. For longevity purposes, there's no clinical reason to choose the brand name over the generic. The only difference is price — brand-name Rapamune can cost 5-20x more than generic sirolimus at retail pharmacies.

What dose of rapamycin is used for longevity?

Most longevity-focused physicians prescribe rapamycin at doses between 2mg and 10mg once weekly, rather than daily as used in transplant medicine. The once-weekly intermittent dosing is thought to provide mTOR inhibition benefits while allowing immune function to recover between doses. Exact dosing is individualized based on labs, health history, and response — there's no universal "right" dose.

Can I get rapamycin without a prescription?

Not legally in the United States. Rapamycin (sirolimus) is a prescription-only medication. Some grey-market overseas suppliers sell it without a prescription, but this comes with serious risks: unverified quality, unknown purity, and no medical oversight to catch side effects like elevated triglycerides or drug interactions. The cost savings aren't worth the unknowns.

How does rapamycin compare in cost to other longevity drugs?

Rapamycin is mid-range compared to other off-label longevity medications. Metformin is often the cheapest at under $10-20/month through discount programs. Rapamycin runs $20-60/month compounded. GLP-1 drugs like semaglutide are typically hundreds of dollars per month. For the evidence base rapamycin has in preclinical and early human data, the cost-per-evidence ratio is considered favorable by most longevity physicians.

Citations
  1. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392-395. https://doi.org/10.1038/nature08221
  2. Mannick JB, Del Giudice G, Lattanzi M, et al. mTOR inhibition improves immune function in the elderly. Science Translational Medicine. 2014;6(268):268ra179. https://doi.org/10.1126/scitranslmed.3009892
  3. Arriola Apelo SI, Lamming DW. Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island. Journals of Gerontology: Series A. 2016;71(7):841-849. https://doi.org/10.1093/gerona/glw090
  4. Blagosklonny MV. Rapamycin for longevity: opinion article. Aging (Albany NY). 2019;11(19):8048-8067. https://doi.org/10.18632/aging.102355
  5. Kaeberlein M, Creevy KE, Promislow DEL. The dog aging project: translational geroscience in companion animals. Mammalian Genome. 2016;27(7-8):279-288. https://doi.org/10.1007/s00335-016-9638-7
  6. Mannick JB, Morris M, Hockey HP, et al. TORC1 inhibition enhances immune function and reduces infections in the elderly. Science Translational Medicine. 2018;10(449):eaaq1564. https://doi.org/10.1126/scitranslmed.aaq1564
  7. Lamming DW, Ye L, Katajisto P, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012;335(6076):1638-1643. https://doi.org/10.1126/science.1215135
  8. Fang Y, Westbrook R, Hill C, et al. Duration of rapamycin treatment has differential effects on metabolism in mice. Cell Metabolism. 2013;17(3):456-462. https://doi.org/10.1016/j.cmet.2013.02.008